Allergoferon beta

Allergoferon beta Medicine

Pharmacy sales terms

According to the recipe.

Pharmacotherapeutic group

  • Glucocorticosteroid for topical use Cytokine [Glucocorticosteroids in combinations]
  • Glucocorticosteroid for topical use cytokine [Ophthalmic agents in combinations]

Special precautions for storage

At a temperature of 2-8 °C.

Keep out of reach of children.

The shelf life of the drug Allegation® beta2 года. Вскрытый флакон хранить не более 30 дней.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Eye and nasal drops 1 ml
active ingredients:  
betamethasone sodium phosphate 1 mg
interferon alpha-2b human recombinant at least 5000 IU
excipients: benzalkonium chloride-0.1 mg, disodium edetate dihydrate-0.5 mg, sodium chloride-3.2 mg, hypromellose-3 mg, potassium dihydrophosphate-3.63 mg, sodium hydrophosphate dodecahydrate-7.13 mg, povidone 8000-5 mg, macrogol 4000-30 mg, macrogol 400-10 mg, purified water-up to 1 ml  
Release form

Eye drops and nasal drops. In a plastic bottle with a dropper dispenser, 5 or 10 ml. 1 fl. in a pack of cardboard.

Nosological classification (ICD-10)

  • H10. 1 Acute atopic conjunctivitis
  • J30 Vasomotor and allergic rhinitis
  • J30. 1 Allergic rhinitis caused by plant pollen

Dosage (Posology) and method of administration

Conjunctival, intranasal.

With allergic conjunctivitis of moderate severity in the acute stage: instillation into the conjunctival sac of each eye 1 drop 3 times a day, followed by a decrease in the multiplicity (the number of injections per day), depending on the therapeutic effect.

With allergic rhinitis of moderate severity in the acute stage: instill in each nasal passage 2 drops 3 times a day, with a gradual decrease in the multiplicity (the number of injections per day), depending on the therapeutic effect.

The duration of treatment is 10 days.

ATC - Anatomical and therapeutic chemical classification

S01BA06 Betamethasone